-
2025-12-15 ArticlesDefense strategies for suspected fraud in online live-streaming for inducing rewardsFor online live-streaming operators who use false personas, fixed language, create ambiguous relationships, false romantic relationships, or use marriage as a cover to fabricate false reasons to induce irrational rewards, they may be suspected of fraud. In this regard, the defense strategy for innocence can take the victim's lack of misunderstanding as the starting point of defense, and use the absence of a causal relationship between fan rewards and fraud as an auxiliary defense point. The key points of a lenient defense mainly include accurately determining the amount of fraud, reducing the responsibility for refunds, and the "victim" having illegal purposes and faults, etc.
-
2025-12-15 ArticlesWhat conditions must be met for a company to terminate a labor contract on the grounds of "significant changes in objective circumstances"?Terminating a labor contract on the grounds of "significant changes in objective circumstances" is a relatively error-prone reason for dismissal. The reason for this lies in the fact that although the law grants certain rights to lay off employees, there are deviations in the understanding of the legal provisions in practice, especially in the operation of the "negotiation" stage, which is prone to be non-standard. This article will, from a practical perspective, deeply dissect this frequent reason for layoffs.
-
2025-12-10 ArticlesAnalysis of the Advertising Compliance Guidelines for "Three Products and One Device" in ShanghaiOn November 24, 2025, the "Compliance Guidelines for Advertising Activities of Drugs, Medical Devices, Health Foods and Special Medical Purpose Formula Foods in Shanghai" (hereinafter referred to as the "Guidelines") was released. This is the first systematic compliance guidance document formulated by Shanghai for the advertising campaign of "three products and one device". This guideline consists of five chapters and 27 articles, providing comprehensive regulations on advertisement review, content requirements, and release norms, and promoting Shanghai's supervision of "three products and one device" advertisements to enter a new stage of refinement. This article intends to analyze the key legal provisions of this guideline from the perspective of internal legal affairs management.
-
2025-12-08 ArticlesExclusive Interview: With Tenacity and Efficiency, Freedom and Openness, and unwavering commitment to the Path of Law - Young Lawyer Yu JiayueIn a legal life, wisdom is as vast as the sea, the original aspiration is as clear as a chime, and virtue and kindness go hand in hand. Every lawyer of Dehehantong, with the original aspiration of serving the people in their hearts, adheres to the service philosophy of "diligence, craftsmanship and excellence", and strides forward with high spirits on the broad road of the rule of law, shining in the fields they love. Dehehantong's "Character Interviews" invite you to explore the diverse lives of Dehe people together.
-
2025-12-05 ArticlesThe determination of competitive relationships in non-compete restriction casesNon-compete restrictions, as an important means of protecting trade secrets, are facing challenges in practice. This article attempts to take the guiding case No. 190 of the Supreme People's Court as the starting point, systematically analyze the transformation of the standards for determining competitive relations from formal review to substantive review, and draw on the relevant market definition theories of China's Anti-Monopoly Law and the methods for determining competitive relations under the Anti-Unfair Competition Law, proposing a three-level review framework. Through case studies, this paper reveals the laws of competitive relationship determination in emerging industries such as the Internet and medicine, and attempts to construct a systematic determination methodology.
-
2025-11-28 ArticlesDeclaration of Concentration of Business Operators in Enterprise Mergers and Acquisitions: A Case Study of the Medical IndustryWith the acceleration of consolidation in the pharmaceutical industry, anti-monopoly review has become a key link in the merger and acquisition process. Especially after the implementation of the new declaration standards, whether to declare, how to declare, and what regulatory risks may be faced have become issues that the legal and investment teams of enterprises must consider in advance. This article, in combination with the latest regulations and recent practical experience, systematically sorts out the reporting requirements for business concentration in the pharmaceutical industry and provides it for your reference.